Steven Mizell - 08 Nov 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
EVP, Chief HR Officer
Signature
/s/ Jon Filderman as Attorney-in-Fact for Steven C. Mizell
Issuer symbol
MRK
Transactions as of
08 Nov 2022
Net transactions value
-$3,541,278
Form type
4
Filing time
10 Nov 2022, 16:01:36 UTC
Previous filing
01 Nov 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Options Exercise $0 +20,000 +62% $0.000000 52,144 08 Nov 2022 Direct
transaction MRK Common Stock Sale $2,020,000 -20,000 -38% $101.00 32,144 08 Nov 2022 Direct
transaction MRK Common Stock Options Exercise $0 +15,000 +47% $0.000000 47,144 10 Nov 2022 Direct
transaction MRK Common Stock Sale $1,521,278 -15,000 -32% $101.42 32,144 10 Nov 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Stock Option (Right to Buy) Options Exercise $0 -20,000 -56% $0.000000 15,824 08 Nov 2022 Common Stock 20,000 $70.71 Direct F3
transaction MRK Stock Option (Right to Buy) Options Exercise $0 -15,000 -95% $0.000000 824 10 Nov 2022 Common Stock 15,000 $70.71 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.4000 to $101.5300, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
F2 Holdings include shares acquired in dividend reinvestment transactions.
F3 The option vested and became exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.